{"disease":{"id":"ewing-s-sarcoma-metastatic","name":"ewing s sarcoma metastatic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06820957","title":"Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":437,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT07321912","title":"Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":406,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT07066982","title":"Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT03495921","title":"A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"Gradalis, Inc.","has_results":true},{"nct_id":"NCT04183062","title":"BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Nicklaus Children's Hospital f/k/a Miami Children's Hospital","has_results":false},{"nct_id":"NCT03842865","title":"Expanded Access of Vigil in Solid Tumors","phase":"","overall_status":"TEMPORARILY_NOT_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Gradalis, Inc.","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}